190 related articles for article (PubMed ID: 37809102)
1. Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review.
Liu CH; Chiu LC; Lee CC; Chan TM
Front Immunol; 2023; 14():1240089. PubMed ID: 37809102
[TBL] [Abstract][Full Text] [Related]
2. Case report: Successful treatment of an anti-D2R and DPPX antibody-associated autoimmune encephalitis patient with high-dose methylprednisolone and intravenous immunoglobulin.
Lin Z; Zhou F; Ni L; Dong S; Fu G; Zhao J
Front Immunol; 2024; 15():1338714. PubMed ID: 38469308
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune GFAP astrocytopathy after viral encephalitis: a case report of bimodal overlapping encephalitis.
Cheng P; Huang W; Yang M; Chen Z; Geng Y; Zhang X; Chen W
Front Immunol; 2023; 14():1258048. PubMed ID: 37781407
[TBL] [Abstract][Full Text] [Related]
4. [High Dose Intravenous Immunoglobulin Therapy for Autoimmune Diseases of the Central Nervous System].
Uzawa A; Kuwabara S
Brain Nerve; 2021 May; 73(5):420-424. PubMed ID: 34006671
[TBL] [Abstract][Full Text] [Related]
5. [Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
Bembeeva RT; Zavadenko NN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):83-93. PubMed ID: 26356621
[TBL] [Abstract][Full Text] [Related]
6. High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis.
Wang J; Lin J; Wang M; Meng Z; Zhou D; Li J
Front Immunol; 2021; 12():774664. PubMed ID: 34975861
[TBL] [Abstract][Full Text] [Related]
7. Failure of IVIG in steroid-responsive autoimmune glial fibrillary acidic protein astrocytopathy: A case report.
Heide ES; Chaudhari A; Pirverdian A; Lai S; Courtney A
Mult Scler Relat Disord; 2021 Jun; 51():102933. PubMed ID: 33866078
[TBL] [Abstract][Full Text] [Related]
8. Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment.
Bir Yucel K; Sutcuoglu O; Yazıcı O; Yıldız Y; Şenol E; Uner A
J Oncol Pharm Pract; 2023 Apr; 29(3):760-763. PubMed ID: 35938177
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review.
Wagner JN; Leibetseder A; Troescher A; Panholzer J; von Oertzen TJ
J Neurol; 2022 Feb; 269(2):712-724. PubMed ID: 33675421
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin for the treatment of childhood encephalitis.
Iro MA; Martin NG; Absoud M; Pollard AJ
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and therapy of enteroviral encephalitis: case report and systematic literature review.
Wagner JN; Leibetseder A; Troescher A; Panholzer J; von Oertzen TJ
Int J Infect Dis; 2021 Dec; 113():93-102. PubMed ID: 34628025
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure.
Rosa-Guerrero P; Trujillo-Aguilera A; Molina J; Navas A; López-Martín C; Jurado A; Rodríguez-Benot A; Torres-De-Rueda Á
Front Immunol; 2021; 12():671013. PubMed ID: 34046038
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of intravenous immunoglobulins in neurology.
Hughes RA; Dalakas MC; Cornblath DR; Latov N; Weksler ME; Relkin N
Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):34-42. PubMed ID: 19883422
[TBL] [Abstract][Full Text] [Related]
16. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
Korsak J
Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
[TBL] [Abstract][Full Text] [Related]
17. A case report of complement C4B deficiency in a patient with steroid and IVIG-refractory anti-NMDA receptor encephalitis.
Chua GT; Zhou D; Ho ACC; Chan SHS; Yu CY; Lau YL
BMC Neurol; 2020 Sep; 20(1):339. PubMed ID: 32900365
[TBL] [Abstract][Full Text] [Related]
18. IVIG therapy in neurological disorders of childhood.
Archelos JJ; Fazekas F
J Neurol; 2006 Sep; 253 Suppl 5():V80-6. PubMed ID: 16998760
[TBL] [Abstract][Full Text] [Related]
19. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy in neurological diseases during pregnancy.
Ringel I; Zettl UK
J Neurol; 2006 Sep; 253 Suppl 5():V70-4. PubMed ID: 16998758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
